mushroom

Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

Cannabinoids

Home » Health and medicine » Cannabinoids

mushroom

Creo successfully completes commercial fermentation run

Producing CBGA and CBG at 28,000 litre commercial scale San Diego, CA – August 4, 2021 – Creo, an ingredient technology company with a proprietary platform for producing natural cannabinoids without the cannabis plant...

mushroom

Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG

Hyasynth announces production of >20 rare cannabinoids by fermentation & US patent grant on novel biosynthesis pathway

MONTREAL, QUEBEC, CANADA, May 26, 2021 /EINPresswire.com/ — Hyasynth, a sustainable biotechnology company specializing in fermentation-produced cannabinoid ingredients, today announced an update on its...

mushroom

Octarine Bio announces closing of extended seed round financing of $1.2 million USD with an uptick in valuation due to significant investor demand.

mushroom

Creo becomes first company to achieve demo scale production of rare cannabinoid CBGA

mushroom

Lygos CBx and Metalabs Partner to Co-Develop and Commercialize Haircare Products Featuring Cannabinoids

Lygos and High Beauty Sign Agreement to Co-Develop and Commercialize Cosmetic Products Containing Rare Cannabinoids

mushroom

European synthetic biology company Octarine raises $1.8M USD in funding and enters pre-clinical studies with novel-improved- cannabinoid and psychedelic derivatives

mushroom

Lygos Announces the Launch of Lygos CBx™, a New Low-Cost, Industrial-Scale Cannabinoid Production Company

mushroom

Hyasynth completes key commercialization milestone for cannabinoid biosynthesis, receives $2.5 million payment

mushroom

Renew Biopharma Announces New Executive Leadership to Drive its Drug Discovery Program

mushroom

U.S. Patent Office Grants Renew Biopharma Pivotal Patent for Cannabinoid Biosynthesis

mushroom

Open Book Extracts and Lygos Sign MOU to Co-Develop and Commercialize Nutraceutical Supplement Products Containing Rare Cannabinoids

Jeff Ubersax

Demetrix Is Scaling The Cannabinoid Industry

Jeff Ubersax

Demetrix Begins Demo Scale Production Of Rare Cannabinoids